Advanced Filters
noise

One or multiple investigational sites, Luxembourg Clinical Trials

A listing of One or multiple investigational sites, Luxembourg clinical trials actively recruiting patients volunteers.

Found 65,195 clinical trials
A Ahmed M ElGuindy, MD, MRCP

AHC Ballana Heart Study

This Study is designed to assess CVD incidence, prevalence, progression and related risk factors, including genetic background. It will provide an important base for all cardiovascular research activities in our centre and help in designing future studies and guide policy.

18 years of age All Phase N/A
N Natasha R. Holt

MYLUNG Consortium Part 3: Observational Study

This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.

18 years of age All Phase N/A
J Juhani KE Airaksinen, MD, PhD

TROPOnin FRAGMentation in Myocardial Injury Study

Troponin T (TnT) is a part of the troponin protein complex that principally exists in cardiac and skeletal muscle cells and is widely used as diagnostic biomarker for myocardial injury and, thus, myocardial infarction (MI). Elevated TnT levels can, however, be observed in the presence of other clinical conditions such …

18 years of age All Phase N/A

Tissue Collection Framework To Improve Outcomes In Solid Tumours

Background Cancer therapies have significantly improved over the last decades, allowing cancer specialists to keep cancer under control for longer than ever before. However, metastatic cancer still develops in a large number of patients and drug resistance occurs in the majority of them after an initial period of response and …

18 years of age All Phase N/A

PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

Objectives This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development …

55 - 80 years of age All Phase N/A
F Frederic Frappereau

Data Collection and Evaluation of OptiBP Under Investigational Use

The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.

18 years of age All Phase N/A
E Emily L Klawson, MS

MyPaTH Story Booth

The MyPaTH Story Booth will use an (audio) "document" approach to elicit in depth experiential knowledge or perspectives from patients and caregivers by recording their personal stories.

18 - 99 years of age All Phase N/A
M María Martín, MD

Thoracic Tumours Register

Observational, multicenter study in patients with lung cancer and other thoracic tumors. The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents …

years of age All Phase N/A
A Agnethe Eltoft, MD, PhD

Improving Stroke Care in North-Norway Through Artificial Intelligence

Prospective observational multi-center intervention study. The study aims to evaluate whether an artificial intelligence (AI) support tool for radiological image processing (StrokeSens, Circle NVI) can accelerate decision making and increase detection rate in patients with an acute ischemic stroke caused by intracranial large vessel occlusion (LVO) or medium vessel occlusion …

18 years of age All Phase N/A
J J Coutinho, MD, PhD

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis

Rationale: Patients with cerebral venous thrombosis (CVT) are currently treated with anticoagulants during 3-12 months after diagnosis, to prevent worsening of the CVT and recurrent thrombosis, and to promote venous recanalization. Until recently, patients were generally treated with vitamin K antagonists (VKA). Direct oral anticoagulants (DOACs) are more practical in …

18 years of age All Phase N/A

Simplify language using AI